109 related articles for article (PubMed ID: 33235913)
1. Tumorigenic de-differentiation: the alternative splicing way.
Ray D; Epstein DM
Mol Cell Oncol; 2020 Sep; 7(6):1809959. PubMed ID: 33235913
[TBL] [Abstract][Full Text] [Related]
2. A tumor-associated splice-isoform of
Ray D; Yun YC; Idris M; Cheng S; Boot A; Iain TBH; Rozen SG; Tan P; Epstein DM
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16391-16400. PubMed ID: 32601196
[TBL] [Abstract][Full Text] [Related]
3. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
Pascual M; Vicente M; Monferrer L; Artero R
Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
[TBL] [Abstract][Full Text] [Related]
4. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
Voss DM; Sloan A; Spina R; Ames HM; Bar EE
Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918
[TBL] [Abstract][Full Text] [Related]
5. MBNL1 alternative splicing isoforms play opposing roles in cancer.
Tabaglio T; Low DH; Teo WKL; Goy PA; Cywoniuk P; Wollmann H; Ho J; Tan D; Aw J; Pavesi A; Sobczak K; Wee DKB; Guccione E
Life Sci Alliance; 2018 Oct; 1(5):e201800157. PubMed ID: 30456384
[TBL] [Abstract][Full Text] [Related]
6. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
Terenzi F; Ladd AN
RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing regulation by Muscleblind proteins: from development to disease.
Fernandez-Costa JM; Llamusi MB; Garcia-Lopez A; Artero R
Biol Rev Camb Philos Soc; 2011 Nov; 86(4):947-58. PubMed ID: 21489124
[TBL] [Abstract][Full Text] [Related]
8. Muscleblind isoforms are functionally distinct and regulate alpha-actinin splicing.
Vicente M; Monferrer L; Poulos MG; Houseley J; Monckton DG; O'dell KM; Swanson MS; Artero RD
Differentiation; 2007 Jun; 75(5):427-40. PubMed ID: 17309604
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of miR-294 and MBNL1/2 in shaping the gene regulatory network of embryonic stem cells.
Wu DR; Gu KL; Yu JC; Fu X; Wang XW; Guo WT; Liao LQ; Zhu H; Zhang XS; Hui J; Wang Y
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29735517
[TBL] [Abstract][Full Text] [Related]
10. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins.
Kino Y; Washizu C; Kurosawa M; Oma Y; Hattori N; Ishiura S; Nukina N
Hum Mol Genet; 2015 Feb; 24(3):740-56. PubMed ID: 25274774
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced MBNL1 isoforms exhibit differential influence on enhancing brown adipogenesis.
Hung CS; Lin JC
Biochim Biophys Acta Gene Regul Mech; 2020 Jan; 1863(1):194437. PubMed ID: 31730826
[TBL] [Abstract][Full Text] [Related]
13. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
[TBL] [Abstract][Full Text] [Related]
14. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
15. Splicing regulators in endothelial cell differentiation.
Schiano C; Rienzo M; Casamassimi A; Soricelli A; Napoli C
J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):742-749. PubMed ID: 28661931
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
[TBL] [Abstract][Full Text] [Related]
17. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
[TBL] [Abstract][Full Text] [Related]
18. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
19. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
20. Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1.
Coleman SM; Prescott AR; Sleeman JE
Biochem J; 2014 Mar; 458(2):267-80. PubMed ID: 24354850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
